19 July 2010
Rare Blood Vessel Disease Could Have New Treatment Option
Rituximab could be first new therapy in 40 years against specific forms of vasculitis, researchers say
This article has not necessarily been edited by Health24.
Rituximab may even be superior to cyclophosphamide in treating disease recurrences, the researchers found.
E-cigarettes have become hugely popular in the past decade, but a rash of vaping-linked deaths and illnesses in the US is feeding caution about a product that's already banned in some places.
A new drug works by targeting an immune system antibody called immunoglobulin E, which is responsible for the allergic reaction that causes hives.